In Ghana, infectious diseases continue to constitute a significant component of the national disease burden, even as the country undergoes a broader epidemiological transition. Communicable diseases remain leading causes of morbidity and mortality, particularly among vulnerable populations such as children under five and low-income communities.
Burden and Epidemiological Profile
The infectious disease landscape in Ghana is dominated by malaria, HIV/AIDS, tuberculosis (TB), and diarrhoeal and acute respiratory infections. Malaria alone accounts for approximately 30–40% of outpatient cases and remains a principal cause of hospital admissions and deaths among young children. HIV prevalence among adults is estimated at 1.6–2%, while tuberculosis incidence remains relatively high at around 140 cases per 100,000 population. In addition, periodic outbreaks of diseases such as cholera and meningitis underscore ongoing public health vulnerabilities linked to sanitation, population density, and climatic factors.
Institutional Framework and Management
The management of infectious diseases in Ghana is led by the Ghana Health Service under the policy direction of the Ministry of Health, with technical and financial support from partners such as the World Health Organization. Ghana has developed a structured and multi-layered response framework that integrates prevention, surveillance, and treatment.
A central pillar of this response is the Expanded Programme on Immunization (EPI), which has significantly reduced vaccine-preventable diseases such as measles, polio, and tuberculosis. Malaria control efforts combine vector control strategies—including insecticide-treated nets and indoor residual spraying—with preventive therapies for high-risk groups and improved access to effective antimalarial treatment.
For HIV/AIDS and TB, Ghana has adopted globally recommended approaches, including antiretroviral therapy (ART) and the Directly Observed Treatment Short-course (DOTS) strategy, both of which have contributed to improved treatment outcomes and reduced transmission.
Surveillance and Health Systems Response
Disease surveillance has been strengthened through integrated systems designed to ensure early detection and rapid response to outbreaks. These systems are increasingly supported by digital health platforms, enhancing real-time data reporting and coordination across regions. The National Health Insurance Scheme further underpins access by reducing financial barriers to diagnosis and treatment for many infectious conditions.
Persistent Challenges
Despite these advances, several structural constraints continue to limit effectiveness. These include inadequate water, sanitation, and hygiene (WASH) infrastructure, particularly in rural and peri-urban areas; health workforce and resource limitations; and periodic disruptions in supply chains for essential medicines and commodities. Additionally, the emergence and re-emergence of infectious threats, including viral outbreaks, highlight ongoing vulnerabilities within the system.
Conclusion
Ghana’s response to infectious diseases reflects a well-established but still evolving public health system**, characterized by strong policy frameworks and targeted interventions. While measurable progress has been achieved in reducing the burden of several major diseases, sustaining these gains will require continued investment in infrastructure, surveillance, and preventive health systems—particularly in the context of a dual burden of disease driven by the simultaneous rise of non-communicable conditions.